Pramod Sahadevan

Dr. Pramod Sahadevan

Regenerative Medicine, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2014 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Open access
PDF file
PSPramod Sahadevan
Pramod Sahadevan
KSK. Shivakumar
K. Shivakumar
Cardiac fibroblast hyperplasia associated with enhanced matrix deposition is a major determinant of tissue remodeling in several disease states of the heart. However, mechanisms controlling cell cycle progression in cardiac fibroblasts remain unexplored. Identification of cell cycle regulatory elements in these cells is important to develop strategies to check adverse cardiac remodeling under pathological conditions. This study sought to probe the mechanisms underlying ERK1/2-mediated p27Kip1 regulation in mitogenically stimulated cardiac fibroblasts. Addition of 10% fetal calf serum to quiescent cultures of adult rat cardiac fibroblasts promoted ERK1/2 activation, as evidenced by its phosphorylation status. Reduction in [3H]thymidine incorporation into DNA increased population doubling time, flow cytometry, and Western blot analysis showing reduced levels of cyclins D and A, p27Kip1 induction, and retinoblastoma protein (Rb) hypophosphorylation in ERK1/2-inhibited cells indicated ERK1/2 dependence of G1-S transition in cardiac fibroblasts. Lack of p27Kip1 protein in serum-stimulated, ERK1/2-active cells was associated with increased levels of Skp2, an E3 ubiquitin ligase for p27Kip1, whose knockdown by RNA interference induced p27Kip1 expression. Further, forced expression of Skp2 in ERK1/2-inhibited cells downregulated p27Kip1. Transcriptional upregulation of p27Kip1 mRNA in ERK1/2-inhibited cells, demonstrated by real-time PCR, correlated with forkhead box O 3a (FOXO3a) transcription factor activation, shown by gel shift assay. FOXO3a knockdown attenuated p27Kip1 mRNA and protein expression in ERK1/2-inhibited cells. We provide evidence for the first time that, in cardiac fibroblasts, activated ERK1/2 regulates p27Kip1 expression transcriptionally and posttranslationally via FOXO3a- and Skp2-dependent mechanisms. Additionally, this study uncovers interesting interactions between critical cell cycle regulatory elements that are only beginning to be understood.

1 July 2017 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
PDF file
SNSherin Ali Nawaito
Sherin Ali Nawaito
DDDharmendra Dingar
Dharmendra Dingar
PSPramod Sahadevan
Pramod Sahadevan
BHBahira Hussein
Bahira Hussein
FSFatiha Sahmi
Fatiha Sahmi
BABruce G Allen
Bruce G Allen
MAPK-activated protein kinase-5 (MK5) is a protein serine/threonine kinase that is activated by p38 MAPK and the atypical MAPKs ERK3 and ERK4. The physiological function(s) of MK5 remains unknown. Here, we examined the effect of MK5 haplodeficiency on cardiac function and myocardial remodeling. At 12 wk of age, MK5 haplodeficient mice (MK5+/−) were smaller than age-matched wild-type littermates (MK5+/+), with similar diastolic function but reduced systolic function. Transverse aortic constriction (TAC) was used to induce chronic pressure overload in 12-wk-old male MK5+/− and MK5+/+ mice. Two weeks post-TAC, heart weight-to-tibia length ratios were similarly increased in MK5+/− and MK5+/+ hearts, as was the abundance of B-type natriuretic peptide and β-myosin heavy chain mRNA. Left ventricular ejection fraction was reduced in both MK5+/+ and MK5+/− mice, whereas regional peak systolic tissue velocities were reduced and isovolumetric relaxation time was prolonged in MK5+/+ hearts but not in MK5+/− hearts. The TAC-induced increase in collagen type 1-α1 mRNA observed in MK5+/+ hearts was markedly attenuated in MK5+/− hearts. Eight weeks post-TAC, systolic function was equally impaired in MK5+/+ and MK5+/− mice. In contrast, the increase in E wave deceleration rate and progression of hypertrophy observed in TAC MK5+/+ mice were attenuated in TAC MK5+/− mice. MK5 immunoreactivity was detected in adult fibroblasts but not in myocytes. MK5+/+, MK5+/−, and MK5−/− fibroblasts all expressed α-smooth muscle actin in culture. Hence, reduced MK5 expression in cardiac fibroblasts was associated with the attenuation of both hypertrophy and development of a restrictive filling pattern during myocardial remodeling in response to chronic pressure overload. NEW & NOTEWORTHY MAPK-activated protein kinase-5 (MK5)/p38-regulated/activated protein kinase is a protein serine/threonine kinase activated by p38 MAPK and/or the atypical MAPKs ERK3 and ERK4. MK5 immunoreactivity was detected in adult ventricular fibroblasts but not in myocytes. MK5 haplodeficiency attenuated the progression of hypertrophy, reduced collagen type 1 mRNA, and protected diastolic function in response to chronic pressure overload.

11 September 2017 in IUBMB Life
Verified
Journal Article
Closed access
PDF file
PSPramod Sahadevan
Pramod Sahadevan
BABruce G Allen
Bruce G Allen

1 July 2019 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
SNSherin Ali Nawaito
Sherin Ali Nawaito
PSPramod Sahadevan
Pramod Sahadevan
FSFatiha Sahmi
Fatiha Sahmi
MGMatthias Gaestel
Matthias Gaestel
ACAngelo Calderone
Angelo Calderone
BABruce G Allen
Bruce G Allen

1 June 2019 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
PDF file
SNSherin Ali Nawaito
Sherin Ali Nawaito
PSPramod Sahadevan
Pramod Sahadevan
MCMarie-Élaine Clavet-Lanthier
Marie-Élaine Clavet-Lanthier
PPPhilippe Pouliot
Philippe Pouliot
FSFatiha Sahmi
Fatiha Sahmi
BABruce G Allen
Bruce G Allen
MK5 is a protein serine/threonine kinase activated by p38, ERK3, and ERK4 MAPKs. MK5 mRNA and immunoreactivity are detected in mouse cardiac fibroblasts, and MK5 haplodeficiency attenuates the increase in collagen 1-α1 mRNA evoked by pressure overload. The present study examined the effect of MK5 haplodeficiency on reparative fibrosis following myocardial infarction (MI). Twelve-week-old MK5+/− and wild-type littermate (MK5+/+) mice underwent ligation of the left anterior descending coronary artery (LADL). Surviving mice were euthanized 8 or 21 days post-MI. Survival rates did not differ significantly between MK5+/+ and MK5+/− mice, with rupture of the LV wall being the primary cause of death. Echocardiographic imaging revealed similar increases in LV end-diastolic diameter, myocardial performance index, and wall motion score index in LADL-MK5+/+ and LADL-MK5+/− mice. Area at risk did not differ between LADL-MK5+/+ and LADL-MK5+/− hearts. In contrast, infarct size, scar area, and scar collagen content were reduced in LADL-MK5+/− hearts. Immunohistochemical analysis of mice experiencing heart rupture revealed increased MMP-9 immunoreactivity in the infarct border zone of LADL-MK5+/− hearts compared with LADL-MK5+/+. Although inflammatory cell infiltration was similar in LADL-MK5+/+ and LADL-MK5+/− hearts, angiogenesis was more pronounced in the infarct border zone of LADL-MK5+/− mice. Characterization of ventricular fibroblasts revealed reduced motility and proliferation in fibroblasts isolated from MK5−/− mice compared with those from both wild-type and haplodeficient mice. siRNA-mediated knockdown of MK5 in fibroblasts from wild-type mice also impaired motility. Hence, reduced MK5 expression alters fibroblast function and scar morphology but not mortality post-MI. NEW & NOTEWORTHY MK5/PRAK is a protein serine/threonine kinase activated by p38 MAPK and/or atypical MAPKs ERK3/4. MK5 haplodeficiency reduced infarct size, scar area, and scar collagen content post-myocardial infarction. Motility and proliferation were reduced in cultured MK5-null cardiac myofibroblasts.

16 February 2021 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
MRMatthieu Ruiz
Matthieu Ruiz
MKMaya Khairallah
Maya Khairallah
DDDharmendra Dingar
Dharmendra Dingar
GVGeorge Vaniotis
George Vaniotis
RKRamzi J. Khairallah
Ramzi J. Khairallah
BABruce G Allen
Bruce G Allen
Background: Mitogen‐activated protein kinase–activated protein kinase‐2 (MK2) is a protein serine/threonine kinase activated by p38α/β. Herein, we examine the cardiac phenotype of pan MK2‐null (MK2 −/− ) mice. Methods and Results: Survival curves for male MK2 +/+ and MK2 −/− mice did not differ (Mantel‐Cox test, P =0.580). At 12 weeks of age, MK2 −/− mice exhibited normal systolic function along with signs of possible early diastolic dysfunction; however, aging was not associated with an abnormal reduction in diastolic function. Both R‐R interval and P‐R segment durations were prolonged in MK2‐deficient mice. However, heart rates normalized when isolated hearts were perfused ex vivo in working mode. Ca 2+ transients evoked by field stimulation or caffeine were similar in ventricular myocytes from MK2 +/+ and MK2 −/− mice. MK2 −/− mice had lower body temperature and an age‐dependent reduction in body weight. mRNA levels of key metabolic genes, including Ppargc1a , Acadm , Lipe , and Ucp3, were increased in hearts from MK2 −/− mice. For equivalent respiration rates, mitochondria from MK2 −/− hearts showed a significant decrease in Ca 2+ sensitivity to mitochondrial permeability transition pore opening. Eight weeks of pressure overload increased left ventricular mass in MK2 +/+ and MK2 −/− mice; however, after 2 weeks the increase was significant in MK2 +/+ but not MK2 −/− mice. Finally, the pressure overload–induced decrease in systolic function was attenuated in MK2 −/− mice 2 weeks, but not 8 weeks, after constriction of the transverse aorta. Conclusions: Collectively, these results implicate MK2 in (1) autonomic regulation of heart rate, (2) cardiac mitochondrial function, and (3) the early stages of myocardial remodeling in response to chronic pressure overload.